- GlobeNewswire•11 days ago
ROCKVILLE, Md., April 13, 2017-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that ...
- Investopedia•24 days ago
These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.
- Accesswire•27 days ago
NEW YORK, NY / ACCESSWIRE / March 28, 2017 / These two stocks posted gains on Monday as they are likely to reduce losses going ahead. Both companies also moved forward with the FDA trials as their lead ...
RNN : Summary for Rexahn Pharmaceuticals, Inc. Co - Yahoo Finance
Rexahn Pharmaceuticals, Inc. (RNN)
NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.41 - 0.43|
|52 Week Range||0.13 - 0.71|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-9.59|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|